NPS
(2S)-2-(6-methoxynaphthalen-2-yl)propanoic acid
Created: | 2007-10-04 |
Last modified: | 2020-06-05 |
Find Related PDB Entry |
---|
Find related ligands: |
---|
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 31 |
Chiral Atom Count | 1 |
Bond Count | 32 |
Aromatic Bond Count | 11 |
Chemical Component Summary | |
---|---|
Name | (2S)-2-(6-methoxynaphthalen-2-yl)propanoic acid |
Synonyms | NAPROXEN |
Systematic Name (OpenEye OEToolkits) | (2S)-2-(6-methoxynaphthalen-2-yl)propanoic acid |
Formula | C14 H14 O3 |
Molecular Weight | 230.259 |
Type | NON-POLYMER |
Chemical Descriptors | |||
---|---|---|---|
Type | Program | Version | Descriptor |
SMILES | ACDLabs | 10.04 | O=C(O)C(c1ccc2c(c1)ccc(OC)c2)C |
SMILES | CACTVS | 3.341 | COc1ccc2cc(ccc2c1)[CH](C)C(O)=O |
SMILES | OpenEye OEToolkits | 1.5.0 | CC(c1ccc2cc(ccc2c1)OC)C(=O)O |
Canonical SMILES | CACTVS | 3.341 | COc1ccc2cc(ccc2c1)[C@H](C)C(O)=O |
Canonical SMILES | OpenEye OEToolkits | 1.5.0 | C[C@@H](c1ccc2cc(ccc2c1)OC)C(=O)O |
InChI | InChI | 1.03 | InChI=1S/C14H14O3/c1-9(14(15)16)10-3-4-12-8-13(17-2)6-5-11(12)7-10/h3-9H,1-2H3,(H,15,16)/t9-/m0/s1 |
InChIKey | InChI | 1.03 | CMWTZPSULFXXJA-VIFPVBQESA-N |
Drug Info: DrugBank
DrugBank ID | DB00788 |
---|---|
Name | Naproxen |
Groups |
|
Description | Naproxen is classified as a nonsteroidal anti-inflammatory dug (NSAID) and was initially approved for prescription use in 1976 and then for over-the-counter (OTC) use in 1994.[A178975] It can effectively manage acute pain as well as pain related to rheumatic diseases, and has a well studied adverse effect profile.[A179098] Given its overall tolerability and effectiveness, naproxen can be considered a first line treatment for a variety of clinical situations requiring analgesia.[A179098] Naproxen is available in both immediate and delayed release formulations, in combination with sumatriptan to treat migraines, and in combination with esomeprazole to lower the risk of developing gastric ulcers.[L6582][L6583][L7309][L7312] |
Synonyms |
|
Brand Names |
|
Indication | Naproxen is indicated for the management of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, polyarticular juvenile idiopathic arthritis, tendinitis, bursitis, acute gout, primary dysmenorrhea, and for the relief of mild to moderate pain.[L6582][L6583][A178975] Further, it is first-line therapy for osteoarthritis, acute gouty arthritis, dysmenorrhea, and musculoskeletal inflammation and pain.[A178975] |
Categories |
|
ATC-Code |
|
CAS number | 22204-53-1 |
Drug Targets
Name | Target Sequence | Pharmacological Action | Actions |
---|---|---|---|
Pancreatic triacylglycerol lipase | MLPLWTLSLLLGAVAGKEVCYERLGCFSDDSPWSGITERPLHILPWSPKD... | unknown | inhibitor |
Prostaglandin G/H synthase 1 | MSRSLLLWFLLFLLLLPPLPVLLADPGAPTPVNPCCYYPCQHQGICVRFG... | unknown | inhibitor |
Prostaglandin G/H synthase 2 | MLARALLLCAVLALSHTANPCCSHPCQNRGVCMSVGFDQYKCDCTRTGFY... | unknown | inhibitor |
Peptostreptococcal albumin-binding protein | MKLNKKLLMAALAGAIVVGGGVNTFAADEPGAIKVDKAPEAPSQELKLTK... | unknown | |
Cytochrome P450 2C8 | MEPFVVLVLCLSFMLLFSLWRQSCRRRKLPPGPTPLPIIGNMLQIDVKDI... | unknown | substrate |
View More |
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
Related Resource References
Resource Name | Reference |
---|---|
Pharos | CHEMBL154 |
PubChem | 156391 |
ChEMBL | CHEMBL154 |
ChEBI | CHEBI:7476 |
CCDC/CSD | COYRUD12, QIMBIA, COYRUD14, COYRUD13, AFOPIX, FEVZUD, QILZIX, COYRUD11, QILZAP, RODSUA, AFOPOD, PAPTUX, RODSOU, QILZOD, TERYEU, QIMCOH, RODSEK, PAMQAX, QIMBEW01, BEYTUW, COYRUD, QIMBAS01, SAJCOY, MICFEJ, COZYAS, QIMBAS, QIMCUN, FEVZUD01, TOBMAA, RODSIO, JULJEH, KETKUT, KETKIH, KETKON |
COD | 7221751, 4501397, 4513532, 7215887, 7215888, 7216530, 7205534, 7218004, 7218005, 2020783, 7209753, 7209755, 4509150 |